Sativa Investments (LON:SATI)

Sativa Investments (LON:SATI)

Share Price
6.75 p
-0.38 (-5.33 %)
Market Cap
£0.00 m
Proactive Investors - Run By Investors For Investors

Sativa Investments

Sativa seeks to invest in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.

Market: NEX:SATI
Sector: Health Care, Equipment & Services
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Sativa Investments

Sativa Investments Timeline

Earlier this month, NEX-listed Sativa, which was set up as a vehicle to invest in medicinal cannabis, announced plans to become a first-mover seed-to-consumer business here in the UK, following the model pioneered in Canada
“PhytoVista provides a UK-based laboratory facility available to all jurisdictions already testing CBD products commercially, and of course able to service the UK market if and when regulatory changes hit the UK too," said Sativa executive director Mark Blower

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use